Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market by Type (Transitional Cell Cancer, Renal cell carcinoma, Renal sarcoma, Others), by Tests (Biopsy, CT Scan, Cystoscopy, Intravenous pyelogram, Kidney Ultrasound) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market by Type (Transitional Cell Cancer, Renal cell carcinoma, Renal sarcoma, Others), by Tests (Biopsy, CT Scan, Cystoscopy, Intravenous pyelogram, Kidney Ultrasound) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 846 | Pages: 138 | November 2016 | Region: Asia Pacific


The Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market was worth $0.84 billion in 2016 and estimated to be growing at a CAGR of 5.92%, to reach $1.12 billion by 2021. Kidney cancer is one of the frequent urologic tumours accounting for around 3% of all human cancers.

Surgical methods alone are sometimes not enough for the treatment of these cancers, mainly in cases where patients acquire metastatic cancers. This is when supplementary treatment routines are suggested and various factors such as immunotherapies and targeted therapies come into equation.

The growth of the Asia-Pacific Kidney Cancer Diagnostics and Therapeutics market is mainly due to the rise in aging population, and increasing awareness towards Kidney Cancer. However, poor accessibility of proper care, volatile economies and lack of awareness in this part of the world are the key factors hindering the growth of the market in this region.

The Asia-Pacific Kidney Cancer Diagnostics and Therapeutics market is segmented based on Type and Tests. The market for Kidney Cancer Diagnostics and Therapeutics, on the basis of Type is segmented into Transitional Cell Cancer, Renal cell carcinoma, Renal sarcoma, and Others. On the basis of Tests, the Kidney Cancer Diagnostics and Therapeutics market is segmented into Biopsy, CT Scan, Cystoscopy, Intravenous pyelogram, Kidney Ultrasound. Biopsy and CT Scan lead the tests segment in the Kidney Cancer Diagnostics and Therapeutics market accounting for more than 50% of the market.

The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. The Asia-Pacific Kidney Cancer Diagnostics and Therapeutics market is anticipated to increase at the highest CAGR during the forecast period due to reasons such as rising aging population, increasing awareness, and strong economic growth in countries such as China, Japan, and Australia.

The major companies dominating the market in this region are GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis, Abbott Laboratories.

1.Introduction                              

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Type                     

                             5.1.1 Transitional Cell Cancer    

                             5.1.2 Renal cell carcinoma         

                             5.1.3 Renal sarcoma     

                             5.1.4 Other Cancers      

              5.2 By Tests                     

                             5.2.1 Biopsy      

                             5.2.2 CT Scan    

                             5.2.3 Cystoscopy            

                             5.2.4 Intravenous pyelogram    

                             5.2.5 Kidney Ultrasound             

6. Geographical Analysis                                         

              6.1 Introduction                           

              6.2 China                         

              6.3 India                          

              6.4 Japan                         

              6.5 South Korea                            

              6.6 Australia                   

7. Pipeline Product Analysis                                    

              7.1 Overview                                 

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8.Strategic Analysis                                    

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9.Market Leaders' Analysis                                     

              9.1 GlaxoSmithKline                    

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Bayer                         

              9.3 Pfizer                         

              9.4 Sanofi S.A                 

              9.5 Hoffmann La Roche              

              9.6 Novartis                    

              9.7 Abbott Laboratories                            

10.Competitive Landscape                                      

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11.Expert Opinions                                    

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2016-2021 (USD Billion)
  2. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Billion)
  3. Asia-Pacific Transitional Cell Cancer Market By Region, From 2016-2021 (USD Billion)
  4. Asia-Pacific Renal cell carcinoma Market By Region, From 2016-2021 (USD Billion)
  5. Asia-Pacific Renal sarcoma Market By Region, From 2016-2021 (USD Billion)
  6. Asia-Pacific Other Kidney Cancers Market By Region, From 2016-2021 (USD Billion)
  7. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2016-2021 (USD Billion)
  8. Asia-Pacific Biopsy Market By Region, From 2016-2021 (USD Billion)
  9. Asia-Pacific CT Scan Market By Region, From 2016-2021 (USD Billion)
  10. Asia-Pacific Cystoscopy Market By Region, From 2016-2021 (USD Billion)
  11. Asia-Pacific Intravenous pyelogram Market By Region, From 2016-2021 (USD Billion)
  12. Asia-Pacific Kidney Ultrasound Market By Region, From 2016-2021 (USD Billion)
  13. China Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Billion)
  14. China Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2016-2021 (USD Billion)
  15. India Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Billion)
  16. India Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2016-2021 (USD Billion)
  17. Japan Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Billion)
  18. Japan Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2016-2021 (USD Billion)
  19. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Billion)
  20. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2016-2021 (USD Billion)
  21. Australia Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Billion)
  22. Australia Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2016-2021 (USD Billion)
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.